SCHEMBL19494889

SCHEMBL19494889

NC(=O)c1cc(SN2CCCCC2)sc1NC(=O)c1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.48
▸ RAB9A P51151 5/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ HTT P42858 2/20 0.48
▸ ALDH1A1 P00352 4/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MAPT P10636 6/20 0.44
▸ TP53 P04637 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ MCL1 Q07820 1/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ LMNA P02545 2/20 0.43
▸ HPGD P15428 2/20 0.42
▸ GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494684 0.90 NPC1 (0.46) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL19494270 0.87 RAB9A (0.48) NPC1RAB9AKDM4EALDH1A1NPSR1
SCHEMBL19494717 0.87 NPC1 (0.46) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL19494637 0.86 NPC1 (0.45) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL19494434 0.86 NPC1 (0.45) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL19494346 0.85 RAB9A (0.41) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL19494688 0.85 MAPT (0.52) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL19494729 0.83 NPC1 (0.42) NPC1RAB9AKDM4EHTTALDH1A1
SCHEMBL19494506 0.81 NPC1 (0.49) NPC1RAB9AKDM4EALDH1A1GLA
SCHEMBL19494409 0.79 IRAK4 (0.48) NPC1RAB9AKDM4EHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback